Skip to main content

Table 1 Search strategy of Embase

From: Comparative efficacy and acceptability of novel biologics in the treatment of myasthenia gravis: systematic review and network meta-analysis of randomized trials

No

Query

#1

'myasthenia gravis'/exp

#2

'myasthenia gravis':ab,ti OR'myasthenia gravis, ocular':ab,ti OR'ocular myasthenia gravis':ab,ti OR'myasthenia gravis, generalized':ab,ti OR'generalized myasthenia gravis':ab,ti OR'muscle-specific receptor tyrosine kinase myasthenia gravis':ab,ti OR'muscle specific receptor tyrosine kinase myasthenia gravis':ab,ti OR'muscle-specific tyrosine kinase antibody positive myasthenia gravis':ab,ti OR'muscle specific tyrosine kinase antibody positive myasthenia gravis':ab,ti OR'musk mg':ab,ti OR'musk myasthenia gravis':ab,ti OR'myasthenia gravis, musk':ab,ti OR'anti-musk myasthenia gravis':ab,ti OR'anti musk myasthenia gravis':ab,ti OR'myasthenia gravis, anti-musk':ab,ti

#3

#1 OR #2

#4

'biological product'/exp

#5

'complement inactivating agents':ab,ti OR'agents, complement inactivating':ab,ti OR'inhibitor, complement':ab,ti OR'complement inhibiting agents':ab,ti OR'complement inhibitors':ab,ti OR eculizumab:ab,ti OR ravulizumab:ab,ti OR'fcrn inhibitor':ab,ti OR efgartigimod:ab,ti OR'efgartigimod alfa plus hyaluronidase':ab,ti OR rozanolixizumab:ab,ti OR nipocalimab:ab,ti OR batoclimab:ab,ti OR'b-cell inhibitors':ab,ti OR rituximab:ab,ti OR inebilizumab:ab,ti OR belimumab:ab,ti OR telitaciept:ab,ti OR zilucoplan:ab,ti

#6

#4 OR #5

#7

#3 AND #6